FTC Issues 2nd Request In Merck-Schering Merger
The companies said they expected the second request as part of the regulatory process under the Hart-Scott-Rodino Antitrust Improvements Act and planned to cooperate fully with the FTC.
Regulators are seeking additional details about a so-called reverse merger the two pharmaceuticals giants announced March 9. Under the deal, Schering will be the surviving public corporation, but will take on...
To view the full article, register now.